epidermal pentapeptide has been researched along with propranolol in 1 studies
| Studies (epidermal pentapeptide) | Trials (epidermal pentapeptide) | Recent Studies (post-2010) (epidermal pentapeptide) | Studies (propranolol) | Trials (propranolol) | Recent Studies (post-2010) (propranolol) |
|---|---|---|---|---|---|
| 20 | 0 | 1 | 33,310 | 3,406 | 3,218 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elgjo, K; Reichelt, KL | 1 |
1 other study(ies) available for epidermal pentapeptide and propranolol
| Article | Year |
|---|---|
Beta-receptor blockade by propranolol modifies the effect of the inhibitory, endogenous epidermal pentapeptide on epidermal cell flux at the G2-M transition but not at the G1-S transition.
Topics: Amino Acid Sequence; Animals; Caffeine; Cyclic AMP; Epidermal Cells; Epidermis; Female; Interphase; Mice; Mice, Hairless; Mitosis; Molecular Sequence Data; Oligopeptides; Propranolol; Pyrrolidonecarboxylic Acid | 1994 |